Vivos Inc. (PC)
Ticker Symbol: USOTC:RDGL
OTC Market Tier: Pink Current
CIK Number: 0001449349
Security Type: Common Stock
RDGL Address: 719 Jadwin Avenue
Richland, Washington 99352
RDGL Country: USA
RDGL Phone: (509) 736-4000
RDGL Fax #: 509-736-4007
Description: Vivos Inc, a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in humans and animals, is pleased to report several significant outcomes after its signature product, IsoPet®, was used to treat a hind-leg soft-tissue sarcoma in a Sheltie at the University of Missouri Veterinary Health Center in Columbia, Missouri.
SIC Code / Description: 3841 / Surgical and medical instruments
Shares Authorized: 2,000,000,000
Shares Outstanding: 1,369,987,688
Shares Outstanding Date: 03/22/2019
Shares Holder Count: 231
Shares Holder Date: 03/25/2019
Market Capitalization: $ 5,068,954.45
Key Executives: George Sharp - Advisor
Dr. Michael Korenko - CEO
Dr. Carlton Cadwell - Chairman
Michael Korenko - Dir.
Leonard Jolliff - CFO
Number of Employees: 11
Incorporation State: DE
Incorporation Country: USA
Incorporation Year: 2006
Auditor: HJ & Associates, LLC
Auditor Address: 50 W Broadway
Suite 600
Salt Lake City, UT 84101
United States
Auditor Website:
IR Firm: N/A
Legal Counsel: N/A
Fiscal Year End: 12/31
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: Pacific Stock Transfer Co.
TA Address: 6725 Via Austi Parkway
Suite 300
Las Vegas, NV 89119
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 38,994
Short Date: 04/30/2019
Closing MMID: 11
BFCMmid: 10
Tier ID: 20
Status: Active
Your Recent History
Vivos Inc.
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:ca D:20190526 00:13:39